Caption Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Caption Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-182,455	Closed	-$328K	–	1966
2022 Q2	$328K	Buy	+182,455	New	+$269K	﹤0.01%	1154
2021 Q1	–	Sell	-21,600	Closed	-$103K	–	1487
2020 Q4	$103K	Buy	21,600 +6,300	+41%	+$31.9K	﹤0.01%	888
2020 Q3	$88K	Sell	15,300 -42,200	-73%	-$252K	﹤0.01%	955
2020 Q2	$388K	Buy	57,500 +33,700	+142%	+$255K	0.01%	714
2020 Q1	$151K	Buy	+23,800	New	+$191K	0.01%	730
2019 Q3	–	Sell	-60,000	Closed	-$485K	–	949
2019 Q2	$892K	Buy	+60,000	New	+$1.08M	0.04%	391
2018 Q4	–	Sell	-16,500	Closed	-$484K	–	681
2018 Q3	$484K	Buy	+16,500	New	+$639K	0.03%	412

Other funds holding CLVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Caption Management's CLVS Position: Q3 2022 in Review

Caption Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2022, closing a stake of 182,455 shares — an estimated $328K sold.

Caption Management first reported a position in CLVS in Q3 2018 and held it in 7 quarters. The position peaked at $892K in Q2 2019. 103 funds tracked by Wall St. Rank hold CLVS as of Q3 2022.

Caption Management reported no remaining Clovis Oncology, Inc. position as of Q3 2022 after selling out during the quarter.
Caption Management sold 182,455 Clovis Oncology, Inc. shares in Q3 2022, an estimated $328K.
Caption Management first reported a position in Clovis Oncology, Inc. in Q3 2018 and held it in 7 quarters.
Caption Management's Clovis Oncology, Inc. position peaked at $892K in Q2 2019.
103 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2022.

Based on Caption Management's 13F filing for Q3 2022, filed 14 Nov 2022.